Article Sidebar

pdf
Date Published: 20/12/2024
Abstract Views: 0
Views pdf: 0
DOI: https://doi.org/10.51298/vmj.v545i2.12231
Issue
Vol. 545 No. 2 (2024)
Section
Các bài báo
How to Cite
Nguyễn, T. H., Quan, K. P., Trần, H. Ân, Ngô, T. T. H., Nguyễn, H. T., & Lâm, Đức T. (2024). ASSESSMENT OF EFFECTIVE PROTECTION OF PREECLAMPSIA-ECLAMPSIA WITH LOW-DOSE ASPIRIN IN HIGH-RISK PREGNANT WOMEN AT CAN THO OBSTETRICS AND GYNECOLOGY HOSPITAL 2020-2022. Vietnam Medical Journal, 545(2). https://doi.org/10.51298/vmj.v545i2.12231

ASSESSMENT OF EFFECTIVE PROTECTION OF PREECLAMPSIA-ECLAMPSIA WITH LOW-DOSE ASPIRIN IN HIGH-RISK PREGNANT WOMEN AT CAN THO OBSTETRICS AND GYNECOLOGY HOSPITAL 2020-2022

Tấn Hưng Nguyễn, Kim Phụng Quan, Hoài Ân Trần, Thị Thuý Hằng Ngô, Hữu Trung Nguyễn, Đức Tâm Lâm

Main Article Content

Abstract

Objectives: To determine the proportion and some related factors of preeclampsia in prophylactic intervention with low-dose aspirin in the screen-positive group in Can Tho Obstetrics and Gynecology Hospital. Materials and methods: Retrospective cohort study on women who came for examination of pregnancy in Can Tho Obstetrics and Gynecology Hospital from January 2020 to June 2022. Results: In the outcomes of 210 women with screen-positive and receiving low-dose aspirin, the proportion of hypertensive disorders of pregnancy is 16.7%, the proportion of preeclampsia is 11.9% and the proportion of chronic hypertension, gestational hypertension, preeclampsia/chronic hypertension are 1.4%; 2.4%; 1.0% respectively. Maternal age of 35 years or older, BMI ≥ 23 kg/m2 or having history of diebetes relate to preeclampsia in the outcome of pregnancy (p<0.05). Conclusions: Hypertensive disorders especially preeclampsia – eclampsia accounted for a high rate in pregnancy. It is necessary to have strategies of prediction of preeclampsia a

Article Details

Keywords

Preeclampsia, eclampsia, prophylactic intervention in hypertensive disorders

References

1. Cao Ngọc Thành, Trương Quang Huy và Võ Văn Khoa, Đánh giá hiệu quả điều trị dự phòng bệnh lý tiền sản giật - sản giật bằng aspirin ở những thai phụ có nguy cơ cao, Tạp chí Phụ Sản. 2015; 13(3), tr. 47-53.
2. World Health Organization, WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. 2011: Geneva.
3. Poon, L.C., et al., The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynaecology & Obstetrics, May 2019; 145 Supply 1: p. 1-33.
4. The American College of Obstetricians and Gynecologists, Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 2020. 135(6): p. e237-e260.
5. The National Institute for Health and Care Excellence guideline, Hypertension in pregnancy: diagnosis and management, NICE, 2019.
6. Magee, L.A., et al., Guideline No. 426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management. Journal of Obstetrics & Gynaecology Canada, 2022. 44(5): p. 547-571 e1.
7. Magee, L.A. and A. Pels, Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary. Journal of Obstetrics & Gynaecology Canada, 2014. 36(5): p. 416-438.
8. Trần Mạnh Linh, Nghiên cứu kết quả sàng lọc bệnh lý tiền sản giật - sản giật bằng xét nghiệm PAPP-A, siêu âm Doppler động mạch tử cung và hiệu quả điều trị dự phòng, Luận văn tiến sĩ Y học, Trường Đại học Y Dược, Đại học Huế, Huế, 2020.
9. Bộ Y tế, Hướng dẫn chẩn đoán và điều trị các bệnh sản phụ khoa, chủ biên, Hà Nội, 2015 tr. 29-34.
10. The American College of Obstetricians and Gynecologists, "Low-Dose Aspirin Use During Pregnancy", Obstetrics & Gynecology. 2018 132(1), pp. e44-e52.